左心室熵是冠状动脉粥样硬化患者主要不良心脏事件的新型预测因子:一项多中心研究
本研究纳入中国两个医疗中心2015年10月至2022年7月间314例接受心血管磁共振延迟钆增强检查的冠状动脉粥样硬化性心脏病患者,其中193例3.0-T场强患者还接受了T1 mapping。结果显示,左心室熵是全因主要不良心脏事件的独立预测因子(HR=1.78,p=0.001),将其加入基线多变量模型可显著提高预后价值(C统计量从0.785升至0.818,DeLong检验p=0.001)。
要点
- 左心室熵是冠状动脉粥样硬化患者主要不良心脏事件的独立预测因子(HR=1.78,p=0.001)。
- 将左心室熵加入包含左心室射血分数和延迟钆增强的基线模型可显著提高预后价值(C统计量0.785升至0.818,p=0.001)。
- 在3.0-T场强患者中,加入左心室熵同样显著提高模型预后价值(C统计量0.820升至0.898,p=0.004)。
核心结论
- 心血管磁共振评估的左心室熵是冠状动脉粥样硬化患者主要不良心脏事件的强有力独立预测因子,其增量预后价值优于常见临床和心血管磁共振危险因素(包括左心室射血分数、延迟钆增强、原生T1和细胞外容积)。
研究设计与样本
- 多中心研究,纳入中国两个医疗中心2015年10月至2022年7月间314例接受心血管磁共振延迟钆增强检查的冠状动脉粥样硬化患者,其中193例3.0-T场强患者还接受了T1 mapping;从延迟钆增强图像计算左心室熵和细胞外容积,分析主要不良心脏事件。
诊断标准与关键数值
- 高熵组主要不良心脏事件风险显著增加(log-rank p<0.001)。
- 在多变量模型中(包含左心室射血分数和延迟钆增强),熵与主要不良心脏事件保持独立关联(HR=1.78;p=0.001)。
- 将左心室熵加入基线多变量模型后,主要终点事件预后价值显著改善(C统计量从0.785升至0.818,DeLong检验p=0.001)。
- 在193例3.0-T场强患者中,将左心室熵加入多变量基线模型后,模型对主要不良心脏事件的预后价值显著改善(C统计量从0.820升至0.898,DeLong检验p=0.004)。
临床应用与阅片要点
- 左心室熵作为心血管磁共振心肌异质性参数,可在指南为基础的临床风险标志物之外提供稳健的预后关联。
- 熵可能在冠状动脉粥样硬化患者主要不良心脏事件的一级预防中发挥重要作用。
- 与延迟钆增强、细胞外容积和原生T1相比,熵可更全面地表征左心室心肌的异质性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To investigate the incremental prognostic value of left ventricular (LV) entropy in a large multi-center population with coronary atherosclerotic heart disease (CAD).
BACKGROUND: Current risk stratification of patients with CAD is imprecise and not accurate enough.
METHODS: A total of 314 CAD patients who underwent cardiovascular magnetic resonance (CMR) late gadolinium enhancement (LGE) at two medical centers in China between October 2015 and July 2022 were included in this study. Additionally, the 193 patients under 3.0-T field also underwent CMR T1 mapping. LV entropy and extracellular volume (ECV) were calculated from the LGE image of LV myocardium, and major adverse cardiac events (MACEs) were analyzed.
RESULTS: Among 314 patients, 110 experienced MACE during a median follow-up of 13 months. The risk of MACE was significantly increased in the high entropy group (log-rank p < 0.001). Entropy maintained an independent association with MACE in a multivariable model including left ventricular ejection fraction (LVEF) and LGE (HR = 1.78; p = 0.001). In addition, the primary endpoint events prognostic value was significantly improved by adding LV entropy to the baseline multivariable model (C-statistic improvement: 0.785-0.818, Delong test: p = 0.001). Similarly, among 193 3.0-T field patients, adding LV entropy to the multivariable baseline model significantly improved the prognostic value of the model for MACE (C-statistic improvement: 0.820-0.898, Delong test: p = 0.004).
CONCLUSION: CMR-assessed LV entropy is a powerful independent predictor of MACE in patients with CAD, incremental to common clinical and CMR risk factors, including LVEF, LGE, Native T1, and ECV.
CLINICAL RELEVANCE STATEMENT: Left ventricular entropy is a powerful independent predictor of major adverse cardiac events in patients with coronary atherosclerotic heart disease, incremental to common clinical and cardiac magnetic resonance risk factors.
KEY POINTS: • Left ventricular entropy, a novel cardiac magnetic resonance parameter of myocardial heterogeneity, demonstrated a robust prognostic association with major adverse cardiac events beyond guideline-based, clinical risk markers. • Entropy can have an important role in the primary prevention of major adverse cardiac events in patients with coronary atherosclerotic heart disease. • Compared with late gadolinium enhancement, extracellular volume, and native T1, entropy could be used to more comprehensively characterize the heterogeneity of left ventricular myocardium.
引用
- Wang WX, Gao Y, Wang J, et al. Left ventricular entropy is a novel predictor of major adverse cardiac events (MACE) in patients with coronary atherosclerosis: a multi-center study. Eur Radiol. 2023. PMID: 37889269. doi:10.1007/s00330-023-10362-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。